Total: 3 |
|
PMID (PMCID) | ||
---|---|---|
24961278 |
MIXED_SAMPLE | Adult |
Unexpectedly high prevalence of rare genetic disorders in kidney transplant recipients with an unknown causal nephropathy. | ||
Quaglia M, Musetti C, Ghiggeri GM, Fogazzi GB, Settanni F, Boldorini RL, Lazzarich E, Airoldi A, Izzo C, Giordano M, Stratta P. Clin Transplant. 2014;28(9):995-1003. |
||
In our center, more than 30% (278/911) of kidney transplant (KTx) recipients were diagnosed with a causal nephropathy: Prevalence of rare genetic disorders in this group was 4.32% (12/278), including 2, 8-dihydroxyadeninuria (2,8-DHA) disease (n=2), HNF-1B-associated nephropathy (n=2), UMOD-related nephropathy (n=5), Fabry disease (n=1), INF2 focal segmental glomerulosclerosis (n=1), and Senior-Loken syndrome (n=1). | ||
24961278 |
MIXED_SAMPLE | Adult |
Unexpectedly high prevalence of rare genetic disorders in kidney transplant recipients with an unknown causal nephropathy. | ||
Quaglia M, Musetti C, Ghiggeri GM, Fogazzi GB, Settanni F, Boldorini RL, Lazzarich E, Airoldi A, Izzo C, Giordano M, Stratta P. Clin Transplant. 2014;28(9):995-1003. |
||
In our center, more than 30% (278/911) of kidney transplant (KTx) recipients were diagnosed with a causal nephropathy: Prevalence of rare genetic disorders in this group was 4.32% (12/278), including 2, 8-dihydroxyadeninuria (2,8-DHA) disease (n=2), HNF-1B-associated nephropathy (n=2), UMOD-related nephropathy (n=5), Fabry disease (n=1), INF2 focal segmental glomerulosclerosis (n=1), and Senior-Loken syndrome (n=1). | ||
24961278 |
MIXED_SAMPLE | Adult |
Unexpectedly high prevalence of rare genetic disorders in kidney transplant recipients with an unknown causal nephropathy. | ||
Quaglia M, Musetti C, Ghiggeri GM, Fogazzi GB, Settanni F, Boldorini RL, Lazzarich E, Airoldi A, Izzo C, Giordano M, Stratta P. Clin Transplant. 2014;28(9):995-1003. |
||
In our center, more than 30% (278/911) of kidney transplant (KTx) recipients were diagnosed with a causal nephropathy: Prevalence of rare genetic disorders in this group was 4.32% (12/278), including 2, 8-dihydroxyadeninuria (2,8-DHA) disease (n=2), HNF-1B-associated nephropathy (n=2), UMOD-related nephropathy (n=5), Fabry disease (n=1), INF2 focal segmental glomerulosclerosis (n=1), and Senior-Loken syndrome (n=1). |